Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-XL 1

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1621-1628

  Han, Zhiyong ^a,c   Chatterjee, Devasis ^a   Early, Janet ^b   Pantazis, Panayotis ^b   Hendrickson, Eric A ^a   Wyche, James H ^a  

^a BROWN UNIVERSITY   (United States)

^b St Joseph's Medical Center Houston   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; CYCLOHEXIMIDE; GENE PRODUCT; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; STAUROSPORINE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CELL ISOLATION; CELL STRAIN HL 60; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ALKALOIDS; APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CYCLOHEXIMIDE; HL-60 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE;

EID: 0029965057     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ameisen, J C., and Capron, A Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis Immunol Today, 12: 102-105, 1991
2. Kosik, K. S. Alzheimer's disease: a cell biological perspective. Science (Washington DC), 256 780-783, 1992.
3. Chen, M-J., Holskin, B., Strickler, J., Gorniak, J., Clark, M. A., Johnson, P. J., Mitcho, M., and Shalloway, D Induction of EIA oncogene expression of cellular susceptibility to lysis by TNF Nature (Lond), 330: 581-583, 1987.
4. Fanidi, A., Harrington, E A., and Evan, G I Cooperative interaction between c-myc and bcl-2 protooncogenes Nature (Lond), 359: 554-556, 1992.
5. Lotem, J , and Sachs, L Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth & Differ., 4 41-47, 1993.
6. Lowe, S. W., Ruley, H. E , Jacks, T., and Housman, D. E p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
7. Kerr, J F. R , Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer, 26: 239-257, 1972.
8. Wyllie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68. 251-307, 1980.
9. Wyllie, A. H., Morris, R. G., Smith, A. L., and Dunlop, D. Chromatin cleavage in apoptosis association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol., 142: 67-77, 1984.
10. Sulston, J. E., and Horvitz, H. R. Post-embryonic cell lineages of the nematode Caenorhabditis elegans. Dev. Biol., 82. 110-156, 1977
11. Sulston, J. E., Schierenberg, E., White, J. G., and Thomson, N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol., 100: 64-119, 1983.
12. Ellis, R. E., Yuan, J., and Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7: 663-698, 1991.
13. Yuan, J., and Horvitz, H. R. Genetic mosaic analyses of ced-3 and ced-4, two genes that control programmed cell death in the nematode C. elegans. Dev. Biol., 138: 33-41, 1990.
14. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M , and Horvitz, H. R. The C elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell, 75. 641-652, 1993.
15. Miura, M., Zhu, H., Rotello, R., Hartweig, E. A., and Yuan, J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75. 653-660, 1993.
16. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E. S. CPP32, a novel apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem., 269: 30761-30764, 1995.
17. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P , Ding, C. K , Gallant, M., Gareau, Y., Griffin, P. R , Labelle, M., Lazebnik, Y. A., Munday, N A , Raju, S. M., Smulson, M. E., Yamin, T-T., Yu, V. L , and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond), 376: 37-43, 1995.
18. Tewari M., Quan, L. T , O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R , Poirier, G. G., Salvesen, G S , and Dixit, V. M. Yama/CPP32b, a mammalian homolog of CED-3, is a Crm-A-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
19. Hengartner, M., Ellis, R. E., and Horvitz, H. R. Caenorhabdins elegans gene ced-9 protects cells from programmed cell death. Nature (Lond.), 356: 494-499, 1992.
20. Cleary, M L., Smith, S D , and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47. 19-28, 1986.
21. Tsujimoto, Y., and Croce, C M Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
22. Hengartner, M. O., and Horvitz, H. R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell, 76: 665-676, 1994.
23. Vaux, D. L , Weissman, I. L., and Kim, S. K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science (Washington DC), 258: 1955-1957, 1992.
24. Vaux, D. L., Haecker, G , and Strasser, A. An evolutionary perspective on apoptosis. Cell. 76: 777-779, 1994.
25. Reed, J C. Bcl-2 and regulation of programmed cell death J Cell Biol , 124: 1-6, 1994.
26. Oltvai, Z N , Milliman, C. L., and Korsmeyer, S. J Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619, 1993.
27. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E , Ding, L., Lindsten, T., Turka, L. A. Mao, X., Nunez, G., and Thompson, C. B bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608, 1993.
28. Sato, T., Hanada, M , Bodrug, S., Iric, S , Iwama, N., Boise, L. H., Thompson, C B., Golemis, E , Fong, L , Wang, H-G., and Reed, J C. Interaction among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA, 91: 9238-9242, 1994
29. Yin, X-M , Oltvai, Z. N , and Korsmeyer, S. J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (Lond.), 369: 321-323, 1994.
30. Oltvai, Z. N., and Korsmeyer, S J. Checkpoints of dueling dimers foil death wishes. Cell. 79: 189-192, 1994.
31. Cho-Chung, Y. S , Clair, T., Tagliaferri, P , Ally, S., Katsaros, D., Tortora, G , Neckers, L., Avery, T. L., Crabtree, G. W., and Robins, R. K. Basic science review: site-selective cyclic AMP analogs as new biological tools in growth control, differentiation and proto-oncogene regulation. Cancer Invest., 7: 161-177, 1989
32. Cho-Chung, Y. S , Clair, T., Tortora, G., and Yokozaki, H. Role of site-specific cAMP analogs in the control and reversal of malignancy Pharmacol. Ther., 50. 1-33, 1991.
33. Chen, M., Quintans, J , Fuks, Z., Thompson, C., Kufe, D. W., and Weichselbaum, R R. Suppression of bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide. Cancer Res., 55 991-994, 1995
34. Han, Z., and Wyche, J. H. Guanosine induces necrosis of cultured aortic endothelial cells. Am. J Pathol., 145: 423-427, 1994.
35. Gough, N. M. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells Anal. Biochem., 173: 93-95, 1988.
36. Pantazis, P., Kozielski, A. J , Mendoza, J T , Early, J. A., Hinz, H. R., and Giovanella, B. C Camptothecin derivatives induce regression of human ovarian carcinomas growth in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro. Int. J Cancer, 53. 863-871, 1993.
37. Tortora, G., Clair, T., and Cho-Chung, Y S An antisense oligodeoxynucleotide targeted against the type 11β regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc. Natl. Acad. Sci. USA, 87. 705-708, 1990.
38. o-benzyl-cyclic adenosine 5′-monophosphate on cell cycle kinetics of HL-60 leukemia cells. Cancer Res., 51: 6263-6267, 1991
39. Martin, S J , Lennon, S. V., Bonham, A. M , and Cotter, T. G. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol , 145: 1859-1867, 1990.
40. Gong, J., Li, X., and Darzynkiewwicz, Z. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin. J. Cell. Physiol , 157: 263-270, 1993
41. Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res., 211: 314-321, 1994.
42. Falcieri E., Martelli, A. M., Bareggi, R , Cataldi, A., and Cocco, L The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation. Biochem Biophys Res. Commun., 193: 19-25, 1993
43. Ishizaki, Y., Voyvodic, J. T., Burne, J. F., and Raff, M. C Control of lens epithelial cell survival. J Cell Biol., 121: 899-908, 1993.
44. Jacobson, M. D , Burne, J. F , King, M. P., Miyashita, T., Reed, J. C., and Raff, M C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature (Lond.), 361: 365-369, 1993.
45. Jacobson, M. D., Burne, J. F., and Raff, M C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
46. Meikrantz, W., Gisselbrecht, S., Tam, S. W., and Schlegel, R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl Acad Sci. USA, 91: 3754-3758, 1994.
47. Veis, D. J. Sorenson, C. M., Shutter, J R., and Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell, 75: 229-240, 1993.
48. Van Lookeren Campagne, M. M., Diaz, F. V., Jastorff, B., and Kessin, R. H. 8-Chloroadenosine 3′,5′-monophosphate inhibits the growth of Chinese hamster ovary and Molt-4 cells through its adenosine metabolite Cancer Res., 51: 1600-1605, 1991
49. Taylor, C. W., and Yeoman, L. C. Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine. Anticancer Drugs, 3: 485-91, 1992.
50. Han, Z , Chatterjee, D., and Wyche, J. H. Proliferation of nontransformed cells is inhibited by adenosine metabolite of but not by parental 8-Cl-cyclic AMP. J. Pharmacol. Exp. Ther., 265: 790-794, 1993.
51. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease Science (Washington DC), 267: 1456-1462, 1995
52. L. Cancer Res., 35: 2262-2265, 1995.
53. Knudson, C. M., Tung, K. S , Tourtellotte, W. G., Brown, G A., and Korsmeyer, S. J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (Washington DC), 270: 96-99, 1995.
54. Gottschalk, A. R., Boise, L. H., Thompson, C. B., and Quintans, J Identification of immunosuppressant-induced apoptosis in murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA, 91: 7350-7354, 1994.
55. Nakayama, K-I., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L E., Lucas, P J., Stewart, V., Alt, F. W., and Loh, D. Y. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science (Washington DC), 261: 1584-1588, 1993.
56. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O , and Korsmeyer, S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection of thymocytes Cell, 67. 879-888, 1991
57. Veis, D. J., Sorenson, C. M., Shutter, J R , and Korsmeyer, S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmentated hair. Cell, 75: 229-240, 1993.
58. Motoyama, N., Wang, F , Roth, K. A., Sawa, H., Nakayama, K-I., Nakayama, K., Negishi, I., Senju, S , Zhang, Q., Fuji, S., and Loh, D. Y. Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science (Washington DC), 267: 1506-1510, 1995
59. Herbert, J. M., Augereau, J. M., Gleye, J. and Maffrand, J. P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 172: 993-999, 1990.
60. Selvakumaran, M., Lin, H-K., Sjin, R. T. T., Reed, J. C., Liebermann, D. A , and Hoffman, B. The novel primary response gene MyD118 and the protooncogenes myb, myc, and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells. Mol. Cell Biol , 14 2352-2360, 1994.
61. Cook, S. J., and McCormick, F. Inhibition by CAMP of Ras-dependent activation of Raf. Science (Washington DC), 262: 1069-1072, 1993.
62. Wu, J., Dent, P., Jelinek, T., Wolfman, A , Weber, M. J., and Sturgill, T W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate Science (Washington DC), 262: 1065-1069, 1993.
63. Marx, J. Two major signal pathways linked. Science (Washington DC), 262: 988-989, 1993.
64. Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
65. Tokiwa, G., Tyers, M , Volpe, T., and Futcher, B. Inhibition of G1 cyclin activity by the Ras/cAMP pathway in yeast. Nature (Lond.), 371: 342-345, 1994.